课题基金 / 基金详情

Accumulation of Genetic Alterations and Chromosome Abnormalities in the Onset and Subsequent Progression of Myelodysplastic Syndromes

Accumulation of Genetic Alterations and Chromosome Abnormalities in the Onset and Subsequent Progression of Myelodysplastic Syndromes
骨髓增生异常综合征的发病和随后的进展中基因改变和染色体异常的积累
批准号:
12670999
负责人:
HORIIKE Shigeo
金额:
$2.05万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

HORIIKE Shigeo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This project on the accumulation of genetic events during the onset and the progression of myelodysplastic syndrome (MDS) revealed three major points as follws:(1) Refined mutational events in the Runt domain of the AML1 gone were identified in 5 patients (2.9%) of 176 patients with myeloid leukemia including 85 with MDS. Among these 5 patients, 4 exclusively showed a frame-shift mutation caused by several base-pairs deletion or insertion, resulting in V93del, 1150ins, I168ins and A120ins, respectively. Longitudinal analyses during their disease course revealed all mutations were detected in the first sample, which means AML1 mutations in MDS may be one of the earliest genetic alterations accumulated during the onset and subsequent disease progression.(2) In order to investigate mutational events in DNA repair genes, we tried to optimize sequencing procedures for 1108 exons of 68 genes, and the optimization for 924 exons has already been finished. Among these 68 genes, we analyzed 97 exons of 6 DNA mismatch repair genes using DNA samples from marrow cells from 48 patients with MDS, 48 with malignant lymphoma, and 48 with AML. Among 79 exons (14753 base-pairs in coding regions) successfully analyzed, 31 mutational events were identified, which involved 7 in hMLH1, 1 in hMSH2, 3 in hMSH6, none in hPMS1, and 9 in hPMS2.(3) We validated the usefulness of the International Prognostic Scoring System (IPSS) in our series of de novo MDS patients. We also revealed the prognostic significance of p53 configurations of those patients, and multivariate analysis uncovered its configuration was the most important prognostic factor, followed by the IPSS risk-stratification. Moreover, within the same IPSS category, patients with a p53 mutation showed significantly shorter survival time than those with wild-type configuration
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
Kita-Sasai Y, Horiike S, Misawa S, Kaneko H, Kobayashi M, et al.: "International prognostic scoring system and TP53 mutations are independent prognostic indicators for patients with myelodysplastic syndrome"British Journal of Haematology. 115(2). 309-312
Kita-Sasai Y、Horiike S、Misawa S、Kaneko H、Kobayashi M等人:“国际预后评分系统和TP53突变是骨髓增生异常综合征患者的独立预后指标”英国血液学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Naoe T, Takeyama K, Yokoazawa T, Kiyoi H, Horiike S, et al.: "Analysis of genetic polymorphism in NQO1,GST-M1,GST-T1,and CYP3A4 in 469 Japanese patients with therapy-related leukemia/MDS and de novo AML"Clinical Cancer Research. 6(10). 4091-4095 (2000)
Naoe T、Takeyama K、Yokoazawa T、Kiyoi H、Horiike S 等人:“469 名日本治疗相关白血病/MDS 患者的 NQO1、GST-M1、GST-T1 和 CYP3A4 基因多态性分析
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Horiike S, Kita-Sasai Y, Nakao M et al.: "Configuration of the TP53 gene as an independent Prognostic parameter of mayelodysplastic syndrome"Leukemia Lymphoma. in press. (2003)
Horiike S、Kita-Sasai Y、Nakao M 等人:“TP53 基因作为骨髓增生异常综合征的独立预后参数的配置”白血病淋巴瘤。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakao M, Horiike S, Okuda T, et al.: "Novel insertion mutations of the hematopoiesis-related transcription factor, AML1/RUNX1, associated with myelodysplastic syndrome"BLOOD. 98(11). 352a (2001)
Nakao M、Horiike S、Okuda T 等人:“与骨髓增生异常综合征相关的造血相关转录因子 AML1/RUNX1 的新插入突变”BLOOD。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
16
    A novel mutation of receptor tyrosine kinase gene, closely associated with leukemic transformation of myelodysplastic syndrome
    • 批准号:
      09671128
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $0.9万
    • 财政年份:
      1997
    • 负责人:
      HORIIKE Shigeo
    • 依托单位:
    海外基金